An Audit Evaluating Anticoagulation Clinic Managed by Clinical Pharmacists in Jordan

Abstract

Background and Objectives :Warfarin is the most widely prescribed oral anticoagulant; it is highly effective for the treatment and prevention of venous and arterial thrombosis. The beneficial outcomes of warfarin therapy are dependent upon achieving and maintaining an optimal international normalized ratio (INR) therapeutic range. The aim of this study was to evaluate the impact of our newly established clinic at Queen Alia Heart Institute (QAHI) in the Royal Medical Services (RMS), Jordan. Patients and Methods:An observational prospective study was carried out in a newly established anticoagulation clinic managed by two clinical pharmacists and one nutritionist in QAHI since September 2013 until June 2014. The patients (no= 250) who were on warfarin for at least two months referred to the clinic were included in our study. All patients or their care givers received a 45 minutes educational session and a warfarin booklet. Then they were followed up regularly for achieving and maintaining the target INR and developing any adverse events related either too high or low INR (>4.5 or 4.5 for one visit. No major thromboembolic or hemorrhagic events were reported. Conclusion:The newly established clinic had achieved a considerable encouraging results and feedbacks in the short period of time since it had been established.